This book is a detailed and comprehensive examination of the contours of drug policy development through the consideration of the particular roles of science, media and interest groups. The author contributes to a richer understanding of the science-policy nexus in the messy, real-world complexities of drug policy, using Belgium as the primary case-study. This book will be of great value to undergraduate and graduate students, as well as to academics, practitioners and policymakers with interest in the science-policy nexus with a particular focus on the drug policy domain.
This book is a detailed and comprehensive examination of the contours of drug policy development through the consideration of the particular roles of science, media and interest groups. The author contributes to a richer understanding of the science-policy nexus in the messy, real-world complexities of drug policy, using Belgium as the primary case-study. This book will be of great value to undergraduate and graduate students, as well as to academics, practitioners and policymakers with interest in the science-policy nexus with a particular focus on the drug policy domain.
Julie Tieberghien is currently a post-doctoral fellow of FWO - Research Foundation Flanders - at the Department of Criminology, Criminal Law & Social Law (Ghent University). Her main areas of research are drug policy analysis, newsmaking, and public criminology, and she has published widely in these areas.
Inhaltsangabe
Preface Acknowledgements 1. Introduction 2. The Science-Policy Nexus: From Knowledge Utilisation Models to the Evidence Movement 3. Analysing Drug Policy: Documents, Elites, and Related Challenges 4. Incremental Steps in the Opening of a Policy Window 5. Parliamentary Working Group on Drugs: 1996-1997 6. Turbulent Intermezzo: 1997-2000 7. The First National Drug Strategy: Federal Drug Policy Note (2001) 8. The Reform of Belgian Drug Law: 2002-2003 9. Concluding Thoughts References
Preface Acknowledgements 1. Introduction 2. The Science-Policy Nexus: From Knowledge Utilisation Models to the Evidence Movement 3. Analysing Drug Policy: Documents, Elites, and Related Challenges 4. Incremental Steps in the Opening of a Policy Window 5. Parliamentary Working Group on Drugs: 1996-1997 6. Turbulent Intermezzo: 1997-2000 7. The First National Drug Strategy: Federal Drug Policy Note (2001) 8. The Reform of Belgian Drug Law: 2002-2003 9. Concluding Thoughts References
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309